Cameron Baker

2 weeks ago | bloomberg.com | Cameron Baker |Greg Ryan

Massachusetts General Hospital in Boston. (Bloomberg) -- The Trump administration’s funding battle with Harvard University is starting to impact projects at affiliated hospitals and has crippled the school’s Center for AIDS Research, one of the largest backers in the US for emerging studies on the condition.

1 month ago | nature.com | Cameron Baker |Kyle Swovick |Francisco A. Chaves |Laura M. Calvi |Archan Ganguly |W. Richard Burack | +4 more

AbstractSignals from the microenvironment are known to be critical for development, stem cell self-renewal and oncogenic progression. Although some niche-driven signals that promote cancer progression have been identified1,2,3,4,5, concerted efforts to map disease-relevant microenvironmental ligands of cancer stem cell receptors have been lacking.

Jan 28, 2025 | msn.com | Katia Porzecanski |Cameron Baker

Continue reading More for You

Jan 28, 2025 | news.bloomberglaw.com | Katia Porzecanski |Cameron Baker

The US Immigration and Customs Enforcement conducted a high-profile operation in the Bronx, joined by recently appointed Homeland Security Secretary Kristi Noem, after hitting Chicago on Sunday. The displays come after President Donald Trump made sweeping moves on immigration as part of his promise to carry out the largest mass deportation in US history, focusing initially on migrants with criminal records. ICE reported on Monday that it had made 1,179 arrests, bringing the total since Jan.

Jan 10, 2025 | news.bloomberglaw.com | Cameron Baker

InflammX Therapeutics to be acquired by Bausch + Lomb, terms of the transaction were not disclosed. InflammX is a biotech company focusing on retinal diseasesPact signed Dec. 2024 gives Bausch the option to buy based on achievement of certain development milestonesTo view the source of this information, click hereTo contact the reporter on this story:Cameron Baker in Boston at [email protected] contact the editor responsible for this story:Zachary Fleming at [email protected]